Global Organ Transplantation Immunosuppressive Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Organ Transplantation Immunosuppressive Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID : 103733
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Organ Transplantation Immunosuppressive Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Organ Transplantation Immunosuppressive Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Kidney Transplant accounting for % of the Organ Transplantation Immunosuppressive Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Calcineurin Inhibitors segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Organ Transplantation Immunosuppressive Drug include AbbVie, Allergan Plc, Astellas Pharma, Bristol-Myers Squibb Company, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Organ Transplantation Immunosuppressive Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Calcineurin Inhibitors

Antiproliferative Agents

mTOR Inhibitors

Antibodies

Steroids

Market segment by Application, can be divided into

Kidney Transplant

Bone Marrow Transplant

Liver Transplant

Heart Transplant

Lungs Transplant

Others Transplant

Market segment by players, this report covers

AbbVie

Allergan Plc

Astellas Pharma

Bristol-Myers Squibb Company

Roche

GlaxoSmithKline plc

Novartis AG

Pfizer

Sanofi S.A.

Veloxis Pharmaceuticals A/S

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Organ Transplantation Immunosuppressive Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Organ Transplantation Immunosuppressive Drug, with revenue, gross margin and global market share of Organ Transplantation Immunosuppressive Drug from 2019 to 2022.

Chapter 3, the Organ Transplantation Immunosuppressive Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Organ Transplantation Immunosuppressive Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Organ Transplantation Immunosuppressive Drug research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Organ Transplantation Immunosuppressive Drug

1.2 Classification of Organ Transplantation Immunosuppressive Drug by Type

1.2.1 Overview: Global Organ Transplantation Immunosuppressive Drug Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type in 2021

1.2.3 Calcineurin Inhibitors

1.2.4 Antiproliferative Agents

1.2.5 mTOR Inhibitors

1.2.6 Antibodies

1.2.7 Steroids

1.3 Global Organ Transplantation Immunosuppressive Drug Market by Application

1.3.1 Overview: Global Organ Transplantation Immunosuppressive Drug Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Kidney Transplant

1.3.3 Bone Marrow Transplant

1.3.4 Liver Transplant

1.3.5 Heart Transplant

1.3.6 Lungs Transplant

1.3.7 Others Transplant

1.4 Global Organ Transplantation Immunosuppressive Drug Market Size & Forecast

1.5 Global Organ Transplantation Immunosuppressive Drug Market Size and Forecast by Region

1.5.1 Global Organ Transplantation Immunosuppressive Drug Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Organ Transplantation Immunosuppressive Drug Market Size by Region, (2017-2022)

1.5.3 North America Organ Transplantation Immunosuppressive Drug Market Size and Prospect (2017-2028)

1.5.4 Europe Organ Transplantation Immunosuppressive Drug Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size and Prospect (2017-2028)

1.5.6 South America Organ Transplantation Immunosuppressive Drug Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Organ Transplantation Immunosuppressive Drug Market Drivers

1.6.2 Organ Transplantation Immunosuppressive Drug Market Restraints

1.6.3 Organ Transplantation Immunosuppressive Drug Trends Analysis

2 Company Profiles

2.1 AbbVie

2.1.1 AbbVie Details

2.1.2 AbbVie Major Business

2.1.3 AbbVie Organ Transplantation Immunosuppressive Drug Product and Solutions

2.1.4 AbbVie Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AbbVie Recent Developments and Future Plans

2.2 Allergan Plc

2.2.1 Allergan Plc Details

2.2.2 Allergan Plc Major Business

2.2.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Product and Solutions

2.2.4 Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Allergan Plc Recent Developments and Future Plans

2.3 Astellas Pharma

2.3.1 Astellas Pharma Details

2.3.2 Astellas Pharma Major Business

2.3.3 Astellas Pharma Organ Transplantation Immunosuppressive Drug Product and Solutions

2.3.4 Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Astellas Pharma Recent Developments and Future Plans

2.4 Bristol-Myers Squibb Company

2.4.1 Bristol-Myers Squibb Company Details

2.4.2 Bristol-Myers Squibb Company Major Business

2.4.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product and Solutions

2.4.4 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Bristol-Myers Squibb Company Recent Developments and Future Plans

2.5 Roche

2.5.1 Roche Details

2.5.2 Roche Major Business

2.5.3 Roche Organ Transplantation Immunosuppressive Drug Product and Solutions

2.5.4 Roche Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Roche Recent Developments and Future Plans

2.6 GlaxoSmithKline plc

2.6.1 GlaxoSmithKline plc Details

2.6.2 GlaxoSmithKline plc Major Business

2.6.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product and Solutions

2.6.4 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.7 Novartis AG

2.7.1 Novartis AG Details

2.7.2 Novartis AG Major Business

2.7.3 Novartis AG Organ Transplantation Immunosuppressive Drug Product and Solutions

2.7.4 Novartis AG Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novartis AG Recent Developments and Future Plans

2.8 Pfizer

2.8.1 Pfizer Details

2.8.2 Pfizer Major Business

2.8.3 Pfizer Organ Transplantation Immunosuppressive Drug Product and Solutions

2.8.4 Pfizer Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Pfizer Recent Developments and Future Plans

2.9 Sanofi S.A.

2.9.1 Sanofi S.A. Details

2.9.2 Sanofi S.A. Major Business

2.9.3 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Product and Solutions

2.9.4 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sanofi S.A. Recent Developments and Future Plans

2.10 Veloxis Pharmaceuticals A/S

2.10.1 Veloxis Pharmaceuticals A/S Details

2.10.2 Veloxis Pharmaceuticals A/S Major Business

2.10.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product and Solutions

2.10.4 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Veloxis Pharmaceuticals A/S Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Organ Transplantation Immunosuppressive Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Organ Transplantation Immunosuppressive Drug Players Market Share in 2021

3.2.2 Top 10 Organ Transplantation Immunosuppressive Drug Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Organ Transplantation Immunosuppressive Drug Players Head Office, Products and Services Provided

3.4 Organ Transplantation Immunosuppressive Drug Mergers & Acquisitions

3.5 Organ Transplantation Immunosuppressive Drug New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Organ Transplantation Immunosuppressive Drug Revenue and Market Share by Type (2017-2022)

4.2 Global Organ Transplantation Immunosuppressive Drug Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Application (2017-2022)

5.2 Global Organ Transplantation Immunosuppressive Drug Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2028)

6.2 North America Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2028)

6.3 North America Organ Transplantation Immunosuppressive Drug Market Size by Country

6.3.1 North America Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2028)

6.3.2 United States Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

6.3.3 Canada Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

6.3.4 Mexico Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2028)

7.2 Europe Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2028)

7.3 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country

7.3.1 Europe Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2028)

7.3.2 Germany Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

7.3.3 France Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

7.3.5 Russia Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

7.3.6 Italy Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2028)

8.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2028)

8.3 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region

8.3.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Region (2017-2028)

8.3.2 China Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8.3.3 Japan Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8.3.4 South Korea Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8.3.5 India Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

8.3.7 Australia Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2028)

9.2 South America Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2028)

9.3 South America Organ Transplantation Immunosuppressive Drug Market Size by Country

9.3.1 South America Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2028)

9.3.2 Brazil Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

9.3.3 Argentina Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2028)

10.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2028)

10.3 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country

10.3.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2028)

10.3.2 Turkey Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

10.3.4 UAE Organ Transplantation Immunosuppressive Drug Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Organ Transplantation Immunosuppressive Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Organ Transplantation Immunosuppressive Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Organ Transplantation Immunosuppressive Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) by Region (2017-2022)

Table 5. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Region (2023-2028)

Table 6. AbbVie Corporate Information, Head Office, and Major Competitors

Table 7. AbbVie Major Business

Table 8. AbbVie Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 9. AbbVie Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Allergan Plc Corporate Information, Head Office, and Major Competitors

Table 11. Allergan Plc Major Business

Table 12. Allergan Plc Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 13. Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Astellas Pharma Major Business

Table 16. Astellas Pharma Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 17. Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors

Table 19. Bristol-Myers Squibb Company Major Business

Table 20. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 21. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Roche Corporate Information, Head Office, and Major Competitors

Table 23. Roche Major Business

Table 24. Roche Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 25. Roche Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 27. GlaxoSmithKline plc Major Business

Table 28. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 29. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 31. Novartis AG Major Business

Table 32. Novartis AG Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 33. Novartis AG Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Pfizer Corporate Information, Head Office, and Major Competitors

Table 35. Pfizer Major Business

Table 36. Pfizer Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 37. Pfizer Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sanofi S.A. Corporate Information, Head Office, and Major Competitors

Table 39. Sanofi S.A. Major Business

Table 40. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 41. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Veloxis Pharmaceuticals A/S Corporate Information, Head Office, and Major Competitors

Table 43. Veloxis Pharmaceuticals A/S Major Business

Table 44. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product and Solutions

Table 45. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Organ Transplantation Immunosuppressive Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Organ Transplantation Immunosuppressive Drug Players Head Office, Products and Services Provided

Table 50. Organ Transplantation Immunosuppressive Drug Mergers & Acquisitions in the Past Five Years

Table 51. Organ Transplantation Immunosuppressive Drug New Entrants and Expansion Plans

Table 52. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) by Type (2017-2022)

Table 53. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Type (2017-2022)

Table 54. Global Organ Transplantation Immunosuppressive Drug Revenue Forecast by Type (2023-2028)

Table 55. Global Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022)

Table 56. Global Organ Transplantation Immunosuppressive Drug Revenue Forecast by Application (2023-2028)

Table 57. North America Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Organ Transplantation Immunosuppressive Drug Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Organ Transplantation Immunosuppressive Drug Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Organ Transplantation Immunosuppressive Drug Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Organ Transplantation Immunosuppressive Drug Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Organ Transplantation Immunosuppressive Drug Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Organ Transplantation Immunosuppressive Drug Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Organ Transplantation Immunosuppressive Drug Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Organ Transplantation Immunosuppressive Drug Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Organ Transplantation Immunosuppressive Drug Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Organ Transplantation Immunosuppressive Drug Picture

Figure 2. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type in 2021

Figure 3. Calcineurin Inhibitors

Figure 4. Antiproliferative Agents

Figure 5. mTOR Inhibitors

Figure 6. Antibodies

Figure 7. Steroids

Figure 8. Organ Transplantation Immunosuppressive Drug Revenue Market Share by Application in 2021

Figure 9. Kidney Transplant Picture

Figure 10. Bone Marrow Transplant Picture

Figure 11. Liver Transplant Picture

Figure 12. Heart Transplant Picture

Figure 13. Lungs Transplant Picture

Figure 14. Others Transplant Picture

Figure 15. Global Organ Transplantation Immunosuppressive Drug Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Organ Transplantation Immunosuppressive Drug Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Region (2017-2028)

Figure 18. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Region in 2021

Figure 19. North America Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Organ Transplantation Immunosuppressive Drug Market Drivers

Figure 25. Organ Transplantation Immunosuppressive Drug Market Restraints

Figure 26. Organ Transplantation Immunosuppressive Drug Market Trends

Figure 27. AbbVie Recent Developments and Future Plans

Figure 28. Allergan Plc Recent Developments and Future Plans

Figure 29. Astellas Pharma Recent Developments and Future Plans

Figure 30. Bristol-Myers Squibb Company Recent Developments and Future Plans

Figure 31. Roche Recent Developments and Future Plans

Figure 32. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 33. Novartis AG Recent Developments and Future Plans

Figure 34. Pfizer Recent Developments and Future Plans

Figure 35. Sanofi S.A. Recent Developments and Future Plans

Figure 36. Veloxis Pharmaceuticals A/S Recent Developments and Future Plans

Figure 37. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Players in 2021

Figure 38. Organ Transplantation Immunosuppressive Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players Organ Transplantation Immunosuppressive Drug Revenue Market Share in 2021

Figure 40. Global Top 10 Players Organ Transplantation Immunosuppressive Drug Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Type in 2021

Figure 43. Global Organ Transplantation Immunosuppressive Drug Market Share Forecast by Type (2023-2028)

Figure 44. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application in 2021

Figure 45. Global Organ Transplantation Immunosuppressive Drug Market Share Forecast by Application (2023-2028)

Figure 46. North America Organ Transplantation Immunosuppressive Drug Sales Market Share by Type (2017-2028)

Figure 47. North America Organ Transplantation Immunosuppressive Drug Sales Market Share by Application (2017-2028)

Figure 48. North America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Country (2017-2028)

Figure 49. United States Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe Organ Transplantation Immunosuppressive Drug Sales Market Share by Type (2017-2028)

Figure 53. Europe Organ Transplantation Immunosuppressive Drug Sales Market Share by Application (2017-2028)

Figure 54. Europe Organ Transplantation Immunosuppressive Drug Revenue Market Share by Country (2017-2028)

Figure 55. Germany Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific Organ Transplantation Immunosuppressive Drug Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific Organ Transplantation Immunosuppressive Drug Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue Market Share by Region (2017-2028)

Figure 63. China Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Organ Transplantation Immunosuppressive Drug Sales Market Share by Type (2017-2028)

Figure 70. South America Organ Transplantation Immunosuppressive Drug Sales Market Share by Application (2017-2028)

Figure 71. South America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa Organ Transplantation Immunosuppressive Drug Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa Organ Transplantation Immunosuppressive Drug Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue Market Share by Country (2017-2028)

Figure 77. Turkey Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz